Efficacy & Safety Evaluation of Enobosarm in Combo With Abemaciclib in Treatment of ER+HER2- Metastatic Breast Cancer
Study sponsor: Veru Inc. · VERU
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2023-10-19Actual
Enrollment · participants5Actual
Source updated2024-02-26Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.